Fig. 9From: Nanotechnology-based ocular drug delivery systems: recent advances and future prospectsa The in vivo IOP of normotensive rats was reduced following 7 days of daily topical application of BT/nDHP and BT/PBS. * P < 0.05. b The daily adjusted averages of △IOP at 12 PM. Each formulation is administered as 2 × 5 μL of 0.1% w/v BT for 7 daysBack to article page